These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23147687)

  • 41. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
    Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
    Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asthma is an independent risk for elevation of plasma C-reactive protein levels.
    Kasayama S; Tanemura M; Koga M; Fujita K; Yamamoto H; Miyatake A
    Clin Chim Acta; 2009 Jan; 399(1-2):79-82. PubMed ID: 18838067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
    Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S
    Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
    González AS; Guerrero DB; Soto MB; Díaz SP; Martinez-Olmos M; Vidal O
    Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals.
    Erden M; Kocaman SA; Poyraz F; Topal S; Sahinarslan A; Boyacı B; Cengel A; Yalçın MR
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):531-9. PubMed ID: 21983762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T; Schmidt EB; Christensen JH
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile.
    Asegaonkar SB; Marathe A; Tekade ML; Cherekar L; Bavikar J; Bardapurkar J; Ajay R
    J Diabetes Complications; 2011; 25(6):368-70. PubMed ID: 22055258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
    Abdullah AR; Hasan HA; Raigangar VL
    Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.
    Geroldi D; Falcone C; Emanuele E; D'Angelo A; Calcagnino M; Buzzi MP; Scioli GA; Fogari R
    J Hypertens; 2005 Sep; 23(9):1725-9. PubMed ID: 16093918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between high-sensitivity CRP and polyclonal free light chains as markers of inflammation in chronic disease.
    Burmeister A; Assi LK; Ferro CJ; Hughes RG; Barnett AH; Bellary S; Cockwell P; Pratt G; Hutchison CA
    Int J Lab Hematol; 2014 Aug; 36(4):415-24. PubMed ID: 24188493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.
    Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products.
    Mulder DJ; van Haelst PL; Gross S; de Leeuw K; Bijzet J; Graaff R; Gans RO; Zijlstra F; Smit AJ
    Atherosclerosis; 2008 Mar; 197(1):217-23. PubMed ID: 17499742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes.
    Fujisawa K; Katakami N; Kaneto H; Naka T; Takahara M; Sakamoto F; Irie Y; Miyashita K; Kubo F; Yasuda T; Matsuoka TA; Shimomura I
    Atherosclerosis; 2013 Apr; 227(2):425-8. PubMed ID: 23384720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients.
    Nakamura K; Adachi H; Matsui T; Kurita Y; Takeuchi M; Yamagishi S
    Metabolism; 2009 Mar; 58(3):421-5. PubMed ID: 19217461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Is there an association of uric acid level with preclinical target organ damage in moderate- and high-risk hypertensive patients?].
    Dmitriev VA; Oshchepkova EV; Titov BN; Rogoza AN; Saidova MA; Bolotova MN; Gushchina OV; Polevaia TY
    Ter Arkh; 2013; 85(9):52-7. PubMed ID: 24261230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.
    Nin JW; Ferreira I; Schalkwijk CG; Prins MH; Chaturvedi N; Fuller JH; Stehouwer CD;
    Diabetologia; 2009 Apr; 52(4):705-14. PubMed ID: 19183936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between vascular inflammation and target organ damage in hypertensive crises.
    Karabacak M; Yigit M; Turkdogan KA; Sert M
    Am J Emerg Med; 2015 Apr; 33(4):497-500. PubMed ID: 25745795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.